New RSV Shot Is a Monoclonal Antibody, Not a Vaccine : vimar

A monoclonal antibody will be offered this fall to prevent respiratory syncytial virus in children. If antibodies are a viable vaccine alternative for kids, will we see new options for adults too?

Related Keywords

Maryland , United States , Cleveland , Ohio , Ruth Karron , Astrazeneca Sanofi , Frank Esper , Centers For Disease , Drug Administration , Disease Control , Johns Hopkins Medicine , Difference Between Vaccines , Cleveland Clinic Children , Respiratory Syncytial Virus Infection , Children , Child , Childhood , Ediatrics , Kids , Biologic Therapy , Monoclonal Antibody , Etuximab , Ituximab , Vaccine , Airway , Fairway Management , Anagement Airway , Autoimmune Disease , Cancer , Alignant Neoplasia , Arcinoma , Centers For Disease Control And Prevention Cdc ,